NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.
- The NPDX AA test can identify ~30% of children with #autism spectrum disorder (ASD) with an increased risk of an AS… https://t.co/R1s2P7oIdB4 hours ago
- The holidays, which can be overstimulating even for neurotypical people, are coming soon. Adults with #autism think… https://t.co/PSA0EFahUn7 hours ago
- Save yourself a phone call – learn from the list of questions and answers about the NPDX AA test, written to addres… https://t.co/UcVH5ssk0119 hours ago